Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Eureka Therapeutics, Inc. — Estrella Immunopharma, Inc. insider · InsiderLens

Home / Insiders / Eureka Therapeutics, Inc.

Eureka Therapeutics, Inc.

10% owner at Estrella Immunopharma, Inc. · on record since Oct 10, 2023

Insider trading activity of Eureka Therapeutics, Inc.

No transactions on record for Eureka Therapeutics, Inc..

Track record of Eureka Therapeutics, Inc.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Eureka Therapeutics, Inc.

Co-insiders of Eureka Therapeutics, Inc.

ALTMAN JEFFREY AEstrella Immunopharma, Inc.
Jia DengyaoEstrella Immunopharma, Inc.
Jiang TaoEstrella Immunopharma, Inc.
Li JianweiEstrella Immunopharma, Inc.
Liu ChengEstrella Immunopharma, Inc.
Long JamesEstrella Immunopharma, Inc.
Owl Creek Asset Management, L.P.Estrella Immunopharma, Inc.
Roberts MarshaEstrella Immunopharma, Inc.
TradeUP Acquisition Sponsor LLCEstrella Immunopharma, Inc.
Twigg WestonEstrella Immunopharma, Inc.
Wen LuqiEstrella Immunopharma, Inc.
Wu FanEstrella Immunopharma, Inc.
Wu Xuejun JanelleEstrella Immunopharma, Inc.
Xu JiandongEstrella Immunopharma, Inc.
Xu PeiEstrella Immunopharma, Inc.
Yang WeiguangEstrella Immunopharma, Inc.
Zhang HongEstrella Immunopharma, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

No transactions on record. Reset filters